Elevation of IL-6 and IL-33 Levels in Serum Associated with Lung Fibrosis and Skeletal Muscle Wasting in a Bleomycin-Induced Lung Injury Mouse Model

Mediators of Inflammation - Tập 2019 - Trang 1-12 - 2019
Jiunn‐Min Shieh1, Hui‐Yun Tseng2,3,4, Fang Jung3, Shih‐Hsing Yang3, Jau‐Chen Lin3
1Division of Chest Medicine, Department of Internal Medicine, Chi Mei Medical Center, Yongkang, Tainan, Taiwan
2Department of Chemistry, Fu Jen Catholic University, New Taipei City, Taiwan
3Department of Respiratory Therapy, Fu Jen Catholic University, New Taipei City, Taiwan
4Graduate Institute of Biomedical and Pharmaceutical Science, Fu Jen Catholic University, New Taipei City, Taiwan

Tóm tắt

Weight loss due to skeletal muscle atrophy in patients with chronic pulmonary disease is negatively correlated with clinical outcome. Pulmonary fibrosis is a chronic and progressive interstitial lung disease characterized by the dysregulated deposition of the extracellular matrix (ECM) with the destruction of normal tissue, resulting in end-stage organ failure. BLM-induced fibrosis is one of several different experimental models of pulmonary fibrosis, characterized by inflammation and excessive ECM deposition. We directly induced mouse lung injury by the intratracheal administration of bleomycin and monitored the physiological and biochemical changes in lung and skeletal muscle tissues by using lung function testing, ELISA, Western blotting, and immunohistochemistry. Here, we found that BLM-induced lung fibrosis with thickened interstitial lung tissue, including fibronectin and collagen, was correlated with the increased serum concentrations of IL-6 and IL-33 and accompanied by reduced lung function, including FRC (functional residual capacity), C chord (lung compliance), IC (inspiratory capacity), VC (vital capacity), TLC (total lung capacity), and FVC (forced vital capacity) (p<0.05). The activity of AKT in lung tissue was suppressed, but conversely, the activity of STAT3 was enhanced during lung fibrosis in mice. In addition, we found that the amount of sST2, the soluble form of the IL-33 receptor, was dramatically decreased in lung fibrosis tissues. The skeletal muscle tissue isolated from lung injury mice increased the activation of STAT3 and AMPK, accompanied by an increased amount of Atrogin-1 protein in BLM-induced lung fibrosis mice. The mouse myoblast cell-based model showed that IL-6 and IL-33 specifically activated STAT3 and AMPK signaling, respectively, to induce the expression of the muscle-specific proteolysis markers MuRF1 and Atrogin-1. These data suggested that increased levels of IL-6 and IL-33 in the serum of mice with BLM-induced lung injury may cause lung fibrosis with thickened interstitial lung tissue accompanied by reduced lung function and muscle mass through the activation of STAT3 and AMPK signals.

Từ khóa


Tài liệu tham khảo

10.1164/rccm.2009-040GL

10.1016/S0140-6736(11)60052-4

10.1002/14651858.CD002880

10.1164/ajrccm/144.2.291

10.1378/chest.125.6.2169

10.1164/rccm.200705-732OC

10.1016/S0140-6736(09)60551-1

10.3978/j.issn.2072-1439.2012.12.07

10.1164/rccm.2108013

10.1038/nrd4467

10.1164/ajrccm.164.10.2104013

10.1164/ajrccm.162.3.9906007

10.1371/journal.pone.0022667

10.1371/journal.pone.0009224

10.1111/j.1365-2222.2004.02013.x

10.1164/ajrccm.163.6.2006064

10.4049/jimmunol.1302470

10.1186/s12931-015-0261-z

10.1371/journal.pone.0022538

10.1007/s00424-008-0574-6

10.1097/MCO.0000000000000273

10.1016/j.cmet.2013.07.012

10.1371/journal.pone.0003331

10.4049/jimmunol.0802387

10.1002/ibd.21175

10.1016/j.jaci.2014.05.011

10.1152/ajplung.00305.2014

10.1371/journal.pone.0121391

10.1136/gut.2009.193599

10.1111/j.1582-4934.2009.00801.x

10.1002/phy2.249

10.1164/rccm.200808-1274OC

10.1073/pnas.092134099

10.1111/j.1476-5381.2011.01247.x

10.4049/jimmunol.170.4.2083

10.1186/1465-9921-12-131

10.1165/rcmb.2008-0487OC

10.1165/ajrcmb.24.4.4249

10.1074/jbc.M114.625715

10.1371/journal.pone.0170561

10.1016/j.immuni.2016.01.009

10.1152/physrev.00011.2008

10.1074/jbc.M705325200

10.1016/S0092-8674(04)00400-3

Thông tin
Thông tin xuất bản

Mediators of Inflammation

Tập 2019

1-12

Thông tin tác giả